GLP-1 and EGF-A dimer (Lepu Medical Technology Beijing)

N/A

Report date: 2026/04/09 20:00:21
NME

Base Information

Drug NameGLP-1 and EGF-A dimer (Lepu Medical Technology Beijing)
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsProprotein convertase subtilisin kexin type 9 inhibitors
TargetsGlucagon-like peptide 1 receptorProprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsObesityDyslipidemiasMetabolic Syndrome +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesLepu Medical Technology (Beijing) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLepu Medical Technology (Beijing) Co Ltd
Inactive CompaniesN/A
Active IndicationsObesityDyslipidemiasMetabolic Syndrome +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A